Arterial Stiffness Predicts Type 2 Diabetes Risk Better Than Hypertension
Arterial stiffness shows better predictive capacity for type 2 diabetes risk than hypertension alone, underscoring the potential utility of arterial stiffness measurements in identifying individuals at higher risk of developing diabetes.
Februery 2023
RAAS Inhibitors Linked to Lower Risk of Intracranial Aneurysm Rupture
Use of renin-angiotensin-aldosterone system (RAAS) inhibitors is significantly associated with a lower risk of rupture of intracranial aneurysms, independent of blood pressure control, offering potential therapeutic implications for aneurysm management.
January 2023
Childhood Cardiovascular Risk Factors and Their Impact on Adult CV Events
Body mass index, systolic blood pressure, total cholesterol level, triglyceride level, and youth smoking are significant childhood cardiovascular risk factors that impact the risk of cardiovascular events in adulthood, underscoring the importance of early intervention and preventive measures.
December 2022
Hospitalized Patients With Severe Hypertension May Not Require Immediate Treatment
Hospitalized patients with severe hypertension may not require immediate treatment, particularly with intravenous antihypertensives, highlighting the importance of individualized management approaches based on clinical assessment and risk stratification.
November 2022
Blood Pressure Hyperresponsiveness to Standing: Implications for Cardiovascular Risk
An increase in systolic blood pressure of more than 6.5 mm Hg when standing is associated with increased cardiovascular risk, underscoring the clinical significance of orthostatic blood pressure changes in cardiovascular health assessment.
November 2022
Hypertension During Pregnancy: Active Treatment Improves Pregnancy Outcomes
Active treatment aiming for a blood pressure goal of less than 140/90 mm Hg is associated with better pregnancy outcomes in women with hypertension during pregnancy, emphasizing the importance of effective blood pressure management in maternal and fetal health.
October 2022
Link Between High Blood Pressure and Diabetes: Neurobiological Insights
Decreased GLP1R expression is associated with sympathetic hyperactivity in rats with cardiometabolic disease, providing neurobiological insights into the link between high blood pressure and diabetes and highlighting potential therapeutic targets for cardiometabolic disorders.
September 2022
Reduced Blood Pressure and Type 2 Diabetes Risk: Clinical Observations
Reducing systolic blood pressure by 5 mm Hg is associated with a lower risk of developing type 2 diabetes, highlighting the potential cardiometabolic benefits of blood pressure management in preventing diabetes onset and improving metabolic health.
September 2022
